N-Power Medicine and NYCBS Partner to Enable Faster, More Efficient Oncology Clinical Trials
N-Power Medicine and NYCBS Partner to Enable Faster, More Efficient Oncology Clinical Trials citybiz
🎗️
Онкология
🎗️Лента новостей
Онкология
Zsofia Stadler Named New Chief of Clinical Genetics Service - Memorial Sloan Kettering Cancer Center
Zsofia Stadler Named New Chief of Clinical Genetics Service - Memorial Sloan Kettering Cancer Center Oncodaily
Онкология
Антидепрессанты против рака: неожиданный союзник в борьбе за жизнь
Антидепрессанты против рака: неожиданный союзник в борьбе за жизнь Наука Mail
Онкология
Онколог Кубеш назвал три часто игнорируемых признака рака
Онколог Кубеш назвал три часто игнорируемых признака рака Здоровье Mail
🎗️
Онкология
Study challenges treatment approach for rare triple-negative breast cancer
Study challenges treatment approach for rare triple-negative breast cancer FemTech World
Онкология
Why Aren't Advanced Cancer Patients Participating in Clinical Trials?
Why Aren't Advanced Cancer Patients Participating in Clinical Trials? MedPage Today
Онкология
Urine cfRNA in Bladder Cancer: Detection and Treatment Response
Urine cfRNA in Bladder Cancer: Detection and Treatment Response Oncodaily
Онкология
RWJBarnabas, Hackensack Meridian Health cited by Becker’s for oncology programs - ROI-NJ
RWJBarnabas, Hackensack Meridian Health cited by Becker’s for oncology programs ROI-NJ
🎗️
Онкология
New Prostate Cancer Foundation Cardiovascular Risk Framework for Patients Receiving Hormone Therapy Published in JCO Oncology Practice
New Prostate Cancer Foundation Cardiovascular Risk Framework for Patients Receiving Hormone Therapy Published in JCO Oncology Practice Business Wire
🎗️
Онкология
Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer Business Wire
Онкология
Cancer Today’s Fall 2026 Issue: Activity-based Groups for Survivors and More | Blog | AACR
Cancer Today’s Fall 2026 Issue: Activity-based Groups for Survivors and More | Blog | AACR American Association for Cancer Research
🎗️
Онкология
N-Power Medicine and New York Cancer & Blood Specialists Partner to Scale Prospective External Control Arms (ProECA) in Community Oncology
N-Power Medicine and New York Cancer & Blood Specialists Partner to Scale Prospective External Control Arms (ProECA) in Community Oncology Business Wire
Онкология
Новые перспективы в лечении трижды негативного рака молочной железы с помощью иммунотерапии.
Новые перспективы в лечении трижды негативного рака молочной железы с помощью иммунотерапии. Vietnam.vn